Streetbeat News

Partnerships

VLKAF

XPEV

XPeng Inc. and Volkswagen Group have entered into a Master Agreement to jointly develop electrical/electronic architecture for vehicles in China. This collaboration will utilize Volkswagen's China Main Platform and Modular Electric Drive Matrix platform, with the first vehicle expected to start production within 24 months.

Portfolio Pulse from charles@benzinga.com

July 22, 2024 | 12:24 am

AMN

BKU

CLVT

EXPI

MARA

NATL

NFE

RIOT

VFC

VIRT

ZETA

Eleven mid-cap stocks performed exceptionally well last week (July 14-July 20). Key performers include Virtu Financial, V.F. Corporation, New Fortress Energy, Riot Platforms, Clarivate, AMN Healthcare Services, BankUnited, Marathon Digital Holdings, eXp World Holdings, Zeta Global Holdings, and NCR Atleos Corporation.

Portfolio Pulse from Lekha Gupta

July 21, 2024 | 4:07 pm

COIN

DHI

EPAM

LEN

MSTR

OQL

STT

TOST

UNH

WBD

Ten large-cap stocks, including Warner Bros. Discovery, Coinbase, and others, were the best performers last week. Key drivers included strategic business plans, earnings beats, and analyst upgrades.

Portfolio Pulse from Lekha Gupta

July 21, 2024 | 1:57 pm

GOOG

GOOGL

JBLU

SAVE

The selection of J.D. Vance as Donald Trump's vice-presidential candidate has raised concerns about the potential breakup of Alphabet Inc (GOOG, GOOGL). Market strategist Jay Woods, however, downplays these concerns, suggesting that Vance's influence may be limited and that Trump would be the primary decision-maker. The news also touches on the potential impact on the cryptocurrency industry and mentions the JetBlue-Spirit Airlines merger.

Portfolio Pulse from Chris Katje

July 21, 2024 | 1:13 pm

BYDDY

HYZN

KARS

TSLA

The EV sector experienced a significant downturn this week, influenced by broader market trends and specific company developments. Tesla raised prices for its Model S and Model X, while Ford shifted its EV production plans. Hyzon Motors saw a sharp decline due to a stock offering, and BYD expanded its dealership network in Vietnam. Additionally, Donald Trump announced plans to end the EV mandate if elected, which could impact the industry.

Portfolio Pulse from Shanthi Rexaline

July 20, 2024 | 3:22 pm

BLK

BTCUSD

The Trump campaign is targeting cryptocurrency voters, with Ohio Senator JD Vance playing a key role. Vance's pro-crypto stance and ownership of Bitcoin are seen as assets to attract the estimated 40 million American crypto owners. This demographic could significantly influence the 2024 election. The Republican Party has updated its platform to oppose the Democrats' regulatory approach to crypto.

Portfolio Pulse from Murtuza Merchant

July 19, 2024 | 8:13 pm

PLTR

WBD

J.D. Vance, a political outsider and former Marine, has been appointed as Donald Trump's running mate. Vance, who has strong ties to Silicon Valley billionaire Peter Thiel, is a best-selling author, Bitcoin enthusiast, and venture capitalist. Both Vance and Thiel are fans of J.R.R. Tolkien's 'The Lord of the Rings,' which has influenced their business ventures. Thiel's companies, including Palantir Technologies Inc (NYSE: PLTR) and Anduril Industries, are named after Tolkien's creations. Warner Bros Discovery Inc (NASDAQ: WBD) also has a connection through the film adaptations of Tolkien's works.

Portfolio Pulse from Natan Ponieman

July 19, 2024 | 8:11 pm

SBUX

Starbucks shares are trading higher following a report that Elliott Investment Management has taken a significant stake in the company. Elliott is pushing for changes to address challenges such as increased competition in China, slowing U.S. growth, and operational issues. Starbucks recently reported weaker-than-expected quarterly sales and profit, with upcoming earnings expected to show an EPS of 94 cents and revenue of $9.24 billion.

Portfolio Pulse from Vaishali Prayag

July 19, 2024 | 8:02 pm

SBUX

Starbucks shares are trading higher following a report suggesting Elliott has an undisclosed stake in the company.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 7:14 pm

SXTP

60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) shares surged by 48% following the announcement of clinical trial agreements for their Tafenoquine Babesiosis study. The company has partnered with Yale University, Rhode Island Hospital, and Tufts Medical Center for the world's first randomized, double-blind, placebo-controlled clinical trial evaluating tafenoquine's efficacy and safety in treating human babesiosis. Patient enrollment has begun, with interim results expected by September 2025.

Portfolio Pulse from Vaishali Prayag

July 19, 2024 | 6:40 pm